Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.590
-0.005 (-0.91%)
At close: Jan 14, 2025, 4:00 PM
0.610
+0.020 (3.41%)
After-hours: Jan 14, 2025, 6:38 PM EST
Adaptimmune Therapeutics Employees
Adaptimmune Therapeutics had 449 employees as of December 31, 2023. The number of employees decreased by 85 or -15.92% compared to the previous year.
Employees
449
Change (1Y)
-85
Growth (1Y)
-15.92%
Revenue / Employee
$389,846
Profits / Employee
-$99,145
Market Cap
150.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ADAP News
- 1 day ago - Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS) - Newsfile Corp
- 26 days ago - Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK - Newsfile Corp
- 6 weeks ago - First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel) - Newsfile Corp
- 2 months ago - Adaptimmune Therapeutics plc (ADAP) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Adaptimmune Reports Q3 2024 Financial and Business Updates - Newsfile Corp
- 2 months ago - Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial - Newsfile Corp
- 2 months ago - Adaptimmune to Participate in Scientific and Medical Conferences this November and December - Newsfile Corp
- 2 months ago - Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024 - Newsfile Corp